HIDEA syndrome
HIDEA syndrome is a syndrome characterized by hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
HIDEA syndrome is a syndrome characterized by hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye abnormalities. It results from mutations in both copies of the P4HTM gene on chromosome 3, which is very highly expressed in the brain and eye. HIDEA syndrome (OMIM #618493) was first characterized in 2019
Presentation
This syndrome affects many body systems, impairing cognition, vision, breathing, and more.
Eyes
Strabismus Difficulty fixing the eyes on an object
Face
Facial features gradually become coarser during childhood.
Musculoskeletal system
Hypotonia Planovalgus Contractures in elbow joints Interphalangeal joint hypermobility
Respiratory system
Hypoventilation Obstructive and central sleep apnea Affected individuals are vulnerable to respiratory distress during infection, such as pneumonia. Respiratory evaluation, including a sleep study, as well as oxygen monitoring at night (pulse oximetry) is valuable as preventative measurements. Anesthesia is a risk for these patients because of their hypoventilation.
Nervous system
P4HTM is very highly expressed throughout the brain. despite these patients having severe intellectual disability, brain MRI is normal in most patients.
Other features
Dysautonomia, often including hypothermia or hyperthermia, and constipation.
Genetics
This condition is caused by mutations in the Prolyl 4-hydroxylase, transmembrane (P4HTM) gene. This gene is located on the short arm of chromosome 3 (3p21.3). Within a cell, Prolyl 4-hydroxylases (P4Hs) play an important role in making collagens and also helping the cell react in the state of hypoxia (lack of oxygen). The inheritance of this condition is autosomal recessive.
Diagnosis
The diagnosis may be suspected on clinical grounds. It is made by sequencing the P4HTM gene.
Management
There is presently no curative treatment for HIDEA syndrome, but the management of respiratory depression with noninvasive or invasive ventilation, even intermittent, is very helpful in many patients.
Epidemiology
The prevalence is not known, but this is considered to be a rare disease. Only 24 patients have been reported to date across the globe, but given its recent discovery, it is expected that there are many more patients left undiagnosed today.
History
This condition was first described in 2014. The causative mutation was discovered in 2019.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1296420654 under CC BY-SA 4.0; modifications have been made.